Price History

Hover for the daily close. The dotted line marks the period open.

Compare PHG with… →

PHG Key Statistics

As of Oct 21, 2026

Trading

Open: $26.08
Previous Close: $26.00
Day's Range: 26.03–26.38
52-Week Range: 23.62–33.44
Volume: 938.93K
Beta: 0.92

Valuation

Market Cap: $25.64B
P/E Ratio: 19.57
Forward P/E: 13.85
PEG Ratio: 0.80
P/S ratio: 1.45
EPS (ttm): 1.34

Financials (FY)

Revenue (FY): $17.83B−1.04%
Net Income (FY): $895.00M
Profit margin: 6.31%
Shares Outstanding: 977.43M
1-Year Return: −4.01%

Dividend and dates

Dividend: $1.01+3.90%
Ex-Dividend Date: May 13, 2026
Earnings Date: November 3, 2026
Avg Volume: 1.07M

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

PHG Stock Return by Calendar Year

Koninklijke Philips N.V. (PHG) 10-year return: what $10,000 became

1 year: $10,000 $9,599; −4.01%
5 years: $10,000 $6,214; −37.86%
10 years: $10,000 $11,342; +13.42%

If you had invested $10,000 in Koninklijke Philips N.V. (PHG) 10 years ago, at the close on October 21, 2016, it would have been worth $11,342 at the close on October 21, 2026: +13.42% in total, +1.27% a year, with dividends reinvested. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

−57.64%+55.64%+0.64%

2016*2017201820192020202120222023202420252026*

Year	Return
2026 (partial year)	+0.64%
2025	+11.25%
2024	+8.53%
2023	+55.64%
2022	−57.64%
2021	−30.75%
2020	+11.00%
2019	+42.23%
2018	−4.92%
2017	+26.68%
2016 (partial year)	+13.85%

As of October 21, 2026.

PHG Revenue and Earnings by Fiscal Year

FY ends December

RevenueNet income

2022202320242025

Fiscal year	Revenue	Net income	Net margin
2025	$17.83B	$895.00M	5.0%
2024	$18.02B	−$702.00M	−3.9%
2023	$18.17B	−$466.00M	−2.6%
2022	$17.83B	−$1.61B	−9.0%

Fiscal year	Revenue	Gross profit	Operating income	Net income	Net margin
2025	$17.83B	$8.06B	$1.45B	$895.00M	5.0%
2024	$18.02B	$7.77B	$513.00M	−$702.00M	−3.9%
2023	$18.17B	$7.45B	−$168.00M	−$466.00M	−2.6%
2022	$17.83B	$7.19B	−$177.00M	−$1.61B	−9.0%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

PHG Dividend History

’17’18’19’21’22’25’26*

$0.97

Dividends per share, 2025 · 1 payments

Year	Dividends per share	Payments	Change
2026*	$1.01	1	—
2025	$0.97	1	—
2022	$0.96	1	−6.7%
2021	$1.03	1	—

Year	Dividends per share	Payments	Change
2026 (partial year)	$1.01	1	—
2025	$0.97	1	—
2022	$0.96	1	−6.7%
2021	$1.03	1	—
2019	$0.96	1	−3.2%
2018	$0.99	1	+14.9%
2017	$0.86	1	—

Most recent payment: $1.01 per share, ex-dividend May 13, 2026. Per-share amounts summed by calendar year from ex-dividend dates. Partial years are shown muted and marked with an asterisk.

PHG Valuation vs Medical Devices Median

Median of 145 stocks

Metric	PHG	Medical Devices median	vs median
P/E	19.57	27.08	28% below
P/S ratio	1.45	2.53	43% below
Profit margin	6.31%	−14.78%	21.1 pts above

Medians across 145 Medical Devices stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.

Recent News

All 7 articles ↓

Koninklijke Philips Q2 Adj. EPS $0.57 Beats $0.40 Estimate, Sales $5.068B Beat $5.040B Estimate
Benzinga2026-07-28

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

The market values Koninklijke Philips N.V. (PHG) at $25.64B. The company sits in the Healthcare sector, in the Medical Devices industry. The company reports 63,670 employees.

The 52-week range on file runs from $23.62 to $33.44. PHG last closed at $26.23 on October 21, 2026. That is +$0.23 (+0.88%) against the previous close. The latest close sits 11.05% above that 52-week low.

Financial Health

In fiscal 2025, Koninklijke Philips N.V. reported revenue of $17.83B. That is −1.04% against the prior fiscal year, when revenue was $18.02B. Net income for the same year was $895.00M. The reported profit margin is 6.31%. That is 21.1 percentage points above the Medical Devices median of −14.78%. Trailing earnings per share are 1.34.

Across the 4 fiscal years on file, revenue moves from $17.83B in 2022 to $17.83B in 2025. Of those 4 years, 1 report positive net income.

Valuation Assessment

On trailing earnings, the shares are priced at 19.57 times earnings. That is 27.73% below the Medical Devices median of 27.08. On forward earnings the ratio is 13.85. The PEG ratio, which sets the P/E against expected earnings growth, reads 0.8. Measured against sales, the shares trade at 1.45 times revenue. On price-to-sales that is 42.63% below the Medical Devices median of 2.53. The medians here are taken across 145 Medical Devices companies that report the metric.

The reported beta is 0.92. Daily returns over the trailing 10 years annualize to a volatility of 31.93%. The trailing one-year total return is −4.01%. Across 10 years the annualized return works out at +1.27%.

Growth & Income

PHG pays a dividend yielding 3.9%. That is 2.7 percentage points above the Medical Devices median yield of 1.15%. The indicated annual rate is $1.01 a share. The ex-dividend date on file is May 13, 2026. Dividends are recorded for 7 calendar years; 2026 shows 1 payments totalling $1.01 a share. The year before, 2025, totalled $0.97 a share.

Across the complete calendar years on file, 2023 returned +55.64% and 2022 returned −57.64%. Of the 9 complete calendar years on file, 6 finished higher. 2026 is still running; the total return is +0.64% year to date.

Peer Comparison

Koninklijke Philips N.V. (PHG) operates in the Medical Devices industry. Here is how it compares to its closest peers by market capitalization:

Company	Ticker	Market Cap	P/E Ratio
Koninklijke Philips N.V.	PHG	$25.64B	19.6
Abbott Laboratories	ABT	$173.92B	32.4
Medtronic plc.	MDT	$119.00B	22.9
Stryker Corporation	SYK	$114.15B	30.8

The Medical Devices industry average P/E ratio is 27.1x. Koninklijke Philips N.V. trades at a P/E of 19.6.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.

Related Medical Devices Stocks

ABT

Abbott Laboratories

$173.92B

MDT

Medtronic plc.

$119.00B

SYK

Stryker Corporation

$114.15B

BSX

Boston Scientific Corporation

$64.33B

EW

Edwards Lifesciences Corporation

$50.95B

GEHC

GE HealthCare Technologies Inc.

$31.17B

View all Medical Devices stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.13T

JNJ

Johnson & Johnson

$621.22B

ABBV

AbbVie Inc.

$503.27B

UNH

UnitedHealth Group Incorporated

$374.30B

MRK

Merck & Co., Inc.

$369.78B

View all Healthcare stocks →

About Koninklijke Philips N.V.

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. It operates through Diagnosis & Treatment, Connected Care, and Personal Health segments. The company provides diagnostic imaging solutions, includes ultrasound business unit, magnetic resonance imaging, computed tomography, and diagnostic x-ray; Image Guided Therapy, including image guided therapy systems and image guided therapy devices. It also offers monitoring, enterprise informatics, and sleep and respiratory care, as well as personal health. Koninklijke Philips N.V. has strategic alliance with WellSpan Health to advanced imaging and diagnostics technology products and platforms. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.

Visit website →

Koninklijke Philips N.V. (PHG) Stock Analysis